Quercetin and Exercise Performance: The VO2max and Post-Exercise Immune Trials

Quercetin is a flavonol concentrated in onions, capers, and apples. Beyond its better-known antioxidant and anti-allergic activity, it has been studied for ergogenic effects since the late 2000s, prompted by mouse data showing improved mitochondrial biogenesis and endurance capacity. The human trial record is mixed but interpretable, and the dose that drives any benefit is consistently around 1 gram per day.

The VO2max meta-analyses

A 2011 meta-analysis by Kressler and colleagues of 11 RCTs reported a small but statistically significant improvement in VO2max of about 1.1 percent with quercetin supplementation over 1 to 8 weeks, and a similarly small endurance-time improvement [1]. The pooled effect size is modest — useful at the elite level where small percentages matter, less meaningful for recreational athletes. A 2019 update by Pelletier and colleagues largely confirmed the signal and noted that trained athletes show smaller responses than untrained subjects [2].

Post-exercise upper respiratory infection

Endurance athletes have elevated rates of upper respiratory tract infection in the weeks after heavy training or competition, an effect linked to transient post-exercise immunosuppression. Nieman and colleagues randomized cyclists doing three days of consecutive cycling to 1 gram per day of quercetin or placebo and found a roughly 36 percent reduction in self-reported URTI in the two weeks following the trial [3]. A separate 12-week observational follow-up replicated the protective signal in community-based recreational athletes [4]. Effect sizes are larger for URTI than for performance metrics, perhaps because immune dysregulation is more reversible than mitochondrial capacity.

Mechanism: mitochondrial biogenesis and AMPK

Quercetin activates AMP-activated protein kinase and sirtuin pathways in skeletal muscle, leading to increased PGC-1-alpha expression and mitochondrial content in mice [5]. Human muscle-biopsy studies have shown smaller but detectable PGC-1-alpha upregulation after 2 weeks of 1 gram daily quercetin [6]. The mechanistic plausibility supports the small VO2max signal even when individual trials underpower the effect.

Doses below 500 mg do nothing

The published trial doses cluster around 1,000 mg per day, typically split as 500 mg twice daily with vitamin C and B vitamins to improve absorption. Quercetin glycosides are poorly absorbed in their native form, so aglycone formulations (especially with isoquercetin or quercetin phytosome) achieve substantially higher plasma levels. Doses in standard 500 mg-per-day allergy products are unlikely to produce the ergogenic or immune effects seen in the cycling trials.

What does not work

Trials in well-trained or elite cyclists, runners, and triathletes show smaller-to-null effects on time-trial performance and lactate threshold compared with the larger effect seen in untrained subjects [7]. Quercetin should not be combined with cyclosporine, fluoroquinolone antibiotics, or warfarin without medical oversight, as it inhibits CYP3A4 and certain transporters. Doses above 1 gram per day for sustained periods have not been adequately studied for safety.